TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0110
+0.0005 (4.76%)
At close: Sep 12, 2025
TrivarX Company Description
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market.
The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.
TrivarX Limited
| Country | Australia |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 6 |
Contact Details
Address: 647 Beaufort Street Mount Lawley, 6050 Australia | |
| Phone | 61 8 6189 1155 |
| Website | trivarx.com |
Stock Details
| Ticker Symbol | TRI |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MEB8 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Kai Sun | Chief Operating Officer |
| Josh Purdy | Public Relations Director |
| Archie Defillo M.D. | Chief Medical Officer |
| Massimiliano Grassi | Head of Artificial Intelligence |
| Dr. Anthony James Keating | Executive Director |
| Stephen Buckley | Company Secretary |